Status:
RECRUITING
A Prospective Registry for Patients at High-Risk for Pancreatic Cancer
Lead Sponsor:
Mayo Clinic
Conditions:
Pancreatic Cancer
Pancreatic Ductal Adenocarcinoma
Eligibility:
All Genders
18+ years
Brief Summary
This study aims to facilitate discovery and validation of tests for early detection in subjects at high risk for pancreatic ductal adenocarcinoma (PDAC) and to facilitate the use of state-of-the-art m...
Eligibility Criteria
Inclusion
- Age ≥ 18 year
- Able to provide written informed consent
- Meets criteria as a High-Risk Individual as defined by protocol
Exclusion
- Individual who has a personal history of pancreatic ductal adenocarcinoma (PDAC)
- History of total pancreatectomy
Key Trial Info
Start Date :
July 13 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
July 31 2031
Estimated Enrollment :
5000 Patients enrolled
Trial Details
Trial ID
NCT06151223
Start Date
July 13 2021
End Date
July 31 2031
Last Update
October 3 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Mayo Clinic in Rochester
Rochester, Minnesota, United States, 55905